# Protein Intake Satiety Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/protein-intake-satiety-randomized-trial-evidence-review
Category: evidence-review
Summary: Protein Intake Satiety Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are
Last reviewed: 2026-05-28
Reviewed by: Migaku Evidence Review
# Protein Intake Satiety Randomized Trial: What the Evidence Says

## Quick Answer

Protein Intake Satiety Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 randomized trial.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Cow’s milk compared to oat drink and its implications for lipid profile– a pilot randomized controlled trial | randomized trial | 2 | 2026-03-18 | 10.1186/s12937-026-01314-w |
| Acute L-Leucine Supplementation and Sprint Exercise Elicit Distinct Appetite and Inflammatory Responses in Persons with Overweight: A Randomized, Counterbalanced, and Crossover Design Study | randomized trial | 2 | 2026-02-13 | 10.3390/nu18040614 |

## What The Sources Report

- Cow's milk is nutrient-dense and, in Norway, national dietary guidelines recommend three daily servings of dairy products including low-fat milk to support adequate calcium and iodine intake. [Rosendahl-Riise Hanne (2026); evidence level 2]
- Current dietary guidelines, including those outlined in the Nordic Nutrition Recommendations (NNR2023), advocate for reduced intake of saturated fat. [Rosendahl-Riise Hanne (2026); evidence level 2]
- A high-carb/high-fat diet increases plasma concentrations of lipopolysaccharides (LPS), tumor necrosis factor alpha (TNF-α), interleukins 1 beta (IL1-β), and IL-6, causing a chronic hyperphagia, insulin resistance, type 2 diabetes, and associated comorbidities. [de França Elias (2026); evidence level 2]
- L-leucine supplementation has been shown to be effective in inducing increased plasma levels of anorectic peptides, with an anorexic effect in animal models by inducing activation in neuron pathways in regions of the central nervous system that are responsible for appetite inhibition. [de França Elias (2026); evidence level 2]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For protein intake satiety randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Rosendahl-Riise Hanne (2026). Cow’s milk compared to oat drink and its implications for lipid profile– a pilot randomized controlled trial. DOI: 10.1186/s12937-026-01314-w. PMCID: PMC13112611. PMID: 41851782. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13112611/
- de França Elias (2026). Acute L-Leucine Supplementation and Sprint Exercise Elicit Distinct Appetite and Inflammatory Responses in Persons with Overweight: A Randomized, Counterbalanced, and Crossover Design Study. DOI: 10.3390/nu18040614. PMCID: PMC12943545. PMID: 41754131. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12943545/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.